916 related articles for article (PubMed ID: 27567363)
1. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
[TBL] [Abstract][Full Text] [Related]
2. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
Lorthe E; Kayem G;
BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
[TBL] [Abstract][Full Text] [Related]
3. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
Roos C; Spaanderman ME; Schuit E; Bloemenkamp KW; Bolte AC; Cornette J; Duvekot JJ; van Eyck J; Franssen MT; de Groot CJ; Kok JH; Kwee A; Merién A; Nij Bijvank B; Opmeer BC; Oudijk MA; van Pampus MG; Papatsonis DN; Porath MM; Scheepers HC; Scherjon SA; Sollie KM; Vijgen SM; Willekes C; Mol BW; van der Post JA; Lotgering FK;
JAMA; 2013 Jan; 309(1):41-7. PubMed ID: 23280223
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers for inhibiting preterm labour and birth.
Flenady V; Wojcieszek AM; Papatsonis DN; Stock OM; Murray L; Jardine LA; Carbonne B
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002255. PubMed ID: 24901312
[TBL] [Abstract][Full Text] [Related]
5. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
[TBL] [Abstract][Full Text] [Related]
6. [Tocolysis for preterm labor without premature preterm rupture of membranes].
Doret M; Kayem G
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1374-1398. PubMed ID: 28029463
[TBL] [Abstract][Full Text] [Related]
7. Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.
van Winden TMS; Nijman TAJ; Kleinrouweler CE; Salim R; Kashanian M; Al-Omari WR; Pajkrt E; Mol BW; Oudijk MA; Roos C
BMC Pregnancy Childbirth; 2022 Jul; 22(1):567. PubMed ID: 35840927
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis.
van Vliet E; Dijkema GH; Schuit E; Heida KY; Roos C; van der Post J; Parry EC; McCowan L; Lyell DJ; El-Sayed YY; Carr DB; Clark AL; Mahdy ZA; Uma M; Sayin NC; Varol GF; Mol BW; Oudijk MA
BJOG; 2016 Oct; 123(11):1753-60. PubMed ID: 27550838
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
van Vliet EOG; Nijman TAJ; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KWM; Scheepers HCJ; Jacquemyn Y; Beek EV; Duvekot JJ; Franssen MTM; Papatsonis DN; Kok JH; van der Post JAM; Franx A; Mol BW; Oudijk MA
Lancet; 2016 May; 387(10033):2117-2124. PubMed ID: 26944026
[TBL] [Abstract][Full Text] [Related]
10. Tocolytics for preterm premature rupture of membranes.
Mackeen AD; Seibel-Seamon J; Grimes-Dennis J; Baxter JK; Berghella V
Cochrane Database Syst Rev; 2011 Oct; (10):CD007062. PubMed ID: 21975760
[TBL] [Abstract][Full Text] [Related]
11. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
[TBL] [Abstract][Full Text] [Related]
12. Tocolytics for preterm premature rupture of membranes.
Mackeen AD; Seibel-Seamon J; Muhammad J; Baxter JK; Berghella V
Cochrane Database Syst Rev; 2014 Feb; (2):CD007062. PubMed ID: 24578236
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
Vis JY; van Baaren GJ; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; van Lith JM; Bolte AC; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvank SW; van Eyck J; Franssen MT; Sollie KM; Woiski M; Vandenbussche FP; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW
Am J Perinatol; 2015 Apr; 32(5):451-60. PubMed ID: 25486290
[TBL] [Abstract][Full Text] [Related]
14. Combination of tocolytic agents for inhibiting preterm labour.
Vogel JP; Nardin JM; Dowswell T; West HM; Oladapo OT
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD006169. PubMed ID: 25010869
[TBL] [Abstract][Full Text] [Related]
15. Effect of nifedipine and atosiban on perinatal brain injury: secondary analysis of the APOSTEL-III trial.
Nijman TAJ; Goedhart MM; Naaktgeboren CN; de Haan TR; Vijlbrief DC; Mol BW; Benders MJN; Franx A; Oudijk MA
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):806-812. PubMed ID: 28452086
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
[TBL] [Abstract][Full Text] [Related]
17. Maintenance nifedipine therapy for preterm symptomatic placenta previa: A randomized, multicenter, double-blind, placebo-controlled trial.
Verspyck E; de Vienne C; Muszynski C; Bubenheim M; Chanavaz-Lacheray I; Dreyfus M; Deruelle P; Benichou J
PLoS One; 2017; 12(3):e0173717. PubMed ID: 28333939
[TBL] [Abstract][Full Text] [Related]
18. Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
van Vliet E; Seinen L; Roos C; Schuit E; Scheepers H; Bloemenkamp K; Duvekot JJ; van Eyck J; Kok JH; Lotgering FK; van Baar A; van Wassenaer-Leemhuis AG; Franssen MT; Porath MM; van der Post J; Franx A; Mol B; Oudijk MA
BJOG; 2016 Jun; 123(7):1107-14. PubMed ID: 26330379
[TBL] [Abstract][Full Text] [Related]
19. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.
Combs CA; Garite TJ; Maurel K; Abril D; Das A; Clewell W; Heyborne K; How H; Huang W; Lewis D; Lu G; Miller H; Nageotte M; Porreco R; Sheikh A; Tran L;
Am J Obstet Gynecol; 2015 Sep; 213(3):364.e1-12. PubMed ID: 25979614
[TBL] [Abstract][Full Text] [Related]
20. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
